Guest post by Lawrence Sellin, PhD.
Pei-Yong Shi was trained in the People’s Republic of China and is now a Professor in the Department of Biochemistry & Molecular Biology at the University of Texas Medical Branch (UTMB) in Galveston.
Since 2007, Pei-Yong Shi has also been an Honorary Professor at the Wuhan Institute of Virology and he has been funded by Dr. Anthony Fauci’s National Institute of Allergy and Infectious Diseases (NIAID) since 2004.
That research has led to Chinese patents assigned to Pei-Yong Shi and the Chinese People’s Liberation Army, in particular, to Cheng Feng Qin.
Pei-Yong Shi, who has been working with the Chinese People’s Liberation Army, is part of a 2021 Fauci grant for $926,569.
Chinese patent application number 201810076027.7 dated October 26, 2018 lists the patent holders as the Academy of Military Sciences of the Chinese People’s Liberation Army and Pei-Yong Shi.
As scientific support, that Chinese patent application cites the 2017 article “A live-attenuated Zika virus vaccine candidate induces sterilizing immunity in mouse models,” which was funded by NIAID grant number AI120942.
A second Chinese patent, WO2019144874A1, dated January 23, 2019, also lists the patent holders as the Academy of Military Sciences of the Chinese People’s Liberation Army and Pei-Yong Shi.
The three scientific articles used to support the claims made in the second Chinese patent were funded by NIAID grants AI120942, AI127744, AI073755 and AI104972.
Strangely, the recipient of NIAID grant AI127744, Tian Wang, does not appear as an author on the Chinese military-dominated article that, nevertheless, cites it as a funding source. So, some type of fund shifting may have occurred.
The final oddity is the August 20, 2015 U.S. patent for “Novel Attenuated Dengue Virus Strains for vaccine application” submitted by Pei-Yong Shi and Cheng Feng Qin, one of the patent holders being the Chinese military’s Beijing Institute of Microbiology and Epidemiology
In that U.S. patent application, Cheng Feng Qin hides his affiliation with the People’s Liberation Army, listing Singapore as his work location.
There are no scientific references in the U.S. patent application and it is unclear from where the financial support came.
To be continued.
Lawrence Sellin, Ph.D. is retired from an international career in business and medical research with 29 years of service in the US Army Reserve and a veteran of Afghanistan and Iraq. His email address is .